Problems viewing or printing? Click here to view online.


march/2007
 

Due to life complications I will be 5-10 minutes late for all meetings. Please note all deliverables and reports are currently running 1-2 days late.

This is how I started 2007. 2007 came in like a lion with work and life colliding. Thankfully most of you were patient with me and I am caught up. Apologies again for my tardiness. My life lesson in 2007 will be delegation and more accurate forecasting.

Since the summer of 2006 Scientific Insights has had the opportunity to work on some very interesting projects including a Virtual Practice for physicians (Physicians met virtual patients by email over a period of 6 months, diagnosed and treated them and then learned from "experts" other treatment options and treatment tips), the Asthma Society's National Strategy, writing scientific papers, and several continuing education lessons for healthcare providers. 2007 sees us leading the R&D efforts of a small nutraceutical company in the US.

bonnie kuehlScientific Insights® looks forward to serving its clients in 2007 with new and interesting projects.

Yours truly,

Bonnie Kuehl, PhD
Executive Director
Scientific Insights® Consulting Group Inc.



 
 
 

Why do we do it this way?








If your answer is "Because I said so", you have given the standard parent response.

If your answer is " Because we have always done it this way", you have given the standard corporate response.

I had the opportunity to hear Stacey Allerton Firth, VP Human Resources of Ford Canada, speak a few weeks ago. Stacey was the lead Ford negotiator during the negotiation of the 2005 CAW (Canadian Auto Workers) agreement. Stacey is not what you would expect a lead negotiator to look like, or even act like - yet this negotiation was widely seen as a major success and a model negotiation for any industry. Stacey's success has come from acting in a non-traditional manner and by building a diverse team to accent her strengths and weaknesses.

Here are some things I learned from Stacey.

For personal and corporate growth to happen we need to start examining why we do things a certain way. We need to start asking some key questions:

  • Exactly why do we do it this way? If you don't remember and no one on your team remembers why, it is probably time to re-think the method.

  • What has been the success rate or benefits of doing it the "standard" way?

  • What have been the failures or limitations of doing it the "standard" way?

If the benefits outweigh the limitations, fantastic, you are on a good path. But, we all need to remember that the world has changed, technology has changed, so we probably should as well. So, we also need to ask:

  • What are there new opportunities we can grasp by doing things differently?

To find the best approaches we need to understand the data, the market, the expectations for success, and the culture around us (our own, our companies, our clients). We need to examine the unique factors we offer and use those differences to our advantage.

 
 
Faith and the Placebo effect

 


The placebo effect has been recognized since it was first described by a French philosopher in 1572; however, clinical medicine took little notice of this effect until the twentieth century. One recent study of physicians found that 60% had used placebos with their patients, and almost 70% of those patients were told they were getting real medicine. One conclusion from this small study was that for the placebo effect to work, patients need to believe in the treatment. The more surprising conclusion was the finding that the relationship between the patient and their doctor was crucial to the effect of a placebo- if patients have faith in their doctor, then even knowingly taking a placebo was found to effective.

The NIH has made identifying placebo effects and how they work a priority in an attempt to exploit the effect therapeutically. The new way of looking at the placebo effect is not to regard it as background "noise" to be subtracted from the results of the clinical trial, but rather to see the placebo effect as a beneficial clinical effect in its own right. It is very common in clinical trials with anti-inflammatory agents to see a large placebo effect. Clinical studies examining the reasons for this have found that the placebo effect can manipulate inflammation by increasing the release of cortisol, which causes both a dampening of the immune response and pain relief.

One problem identified already is the need for patients to believe the treatment will help. The placebo effect appears to require the susceptibility of the patient to suggestion and the ability of the doctor to instill belief in the therapy - this suggestibility of the patient depends on having faith in their doctor. The total effect of the drug then may be a combination of the biological effect of the active ingredient as well as the placebo effect because of patient belief in the ability of the drug to help or "fix", for example through the influencing of cortisol.

While studies are ongoing to further understand and exploit the placebo effect perhaps the greatest impact on medical practice may be through physicians distilling confidence of treatments to their patients through a strong belief that the treatment is the best course of action and will offer the greatest benefits for the patient.


 
 
Places to be Seen

 


Knocking down the Silos - April 23rd at the Mississauga Living Arts Centre. Dave Howlett of the Magnus Group will be speaking about WOMBAT (Word of Mouth Beats all Techniques), his painless networking strategy. See: http://www.torontobiotech.org/pdf/Knocking_Down_Silos.pdf

Research to Revenue September 21st, 2007
Designed for C-level executives featuring fabulous speakers and workshops. Check out the details at http://www.torontobiotech.org/ in late Spring or contact Bonnie directly.


 
 
Scientific Insights®
Scientific Insights® can help you build relationships with investors, healthcare practitioners, sales and marketing teams by being your product or brand expert. We have expertise in both science and medicine including basic and clinical research. We work with you to understand how your product affects and interacts with the body and then help you effectively communicate that information to your key stakeholders.

Find out more about Scientific Insights® at www.scientificinsights.com or contact us directly at bk@scientificinsights.com or 905-823-2745.

Insights is distributed twice a year.  Subscribe at www.scientificinsights.com. Your contact information is never traded, never rented, never sold.

All writing ©2007, Scientific Insights® Consulting Group Inc., unless otherwise noted. The SI logo and Scientific Insights® are registered trademarks of Scientific Insights® Consulting Group Inc.

 


IN THIS ISSUE:


Why do we do it this way?


Faith and the Placebo effect


Places to be seen